3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
38
Colorectal Neoplasms
18
Stomach Neoplasms
7
Biliary Tract Neoplasms
5
Rectal Neoplasms
3
Neoplasm Metastasis
3
Cholangiocarcinoma
3
Neoplasms
2
Metastatic Pancreatic Adenocarcinoma
2
Gastrointestinal Neoplasms
2
Esophageal Neoplasms
2
Wilms Tumor
1
Weight Loss
1
Triple Negative Breast Neoplasms
1
Small Bowel Adenocarcinoma
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Rectal Cancer Patients
1
Pseudomyxoma Peritonei
1
Peritoneal Neoplasms
1
Pancreatic cancer, adult
1
Pancreatic Ductal Adenocarcinoma
1
Pancreatic Diseases
1
Pancreatic Cancer Non-resectable
1
Pancreatic Cancer Metastatic to Liver
1
Pancreatic Adenocarcinoma
1
PDAC - Pancreatic Ductal Adenocarcinoma
1
Ovarian Neoplasms
1
Interventions
Hyperthermic Intraperitoneal Chemotherapy
17
Cisplatin
12
Oxaliplatin
10
Cytoreduction Surgical Procedures
10
Fluorouracil
9
Paclitaxel
8
Mitomycin
8
Leucovorin
6
Surgical Procedures, Operative
4
Doxorubicin
3
Observation
2
Neoadjuvant Therapy
2
Laparoscopy
2
Indocyanine Green
2
Docetaxel
2
Control Groups
2
Chemotherapy, Adjuvant
2
Carboplatin
2
Capecitabine
2
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
tremelimumab
1
sodium thiosulfate
1
pembrolizumab
1
nilotinib
1
lobaplatin
1
irinotecan sucrosofate
1
genexol-PM
1
durvalumab
1
dehydroftorafur
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Peritoneal Neoplasms
×
irinotecan sucrosofate
×
Gastrointestinal
×
Clear all
NCT05277766
2025-07-01
PIPAC-NAL-IRI
University Hospital, Ghent
Phase 1
Recruiting
45 enrolled